Resolute Wealth Strategies’s AbbVie ABBV Stock Holding History

Resolute Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Sell	4,658 -367	-7%	-$79K	0.45%	37
2026 Q1	$1.09M	Buy	5,025 +72	+1%	+$16K	0.47%	36
2025 Q4	$1.13M	Buy	4,953 +2	+0%	+$456	0.5%	35
2025 Q3	$1.15M	Buy	4,951 +1	+0%	+$204	0.52%	33
2025 Q2	$919K	Buy	4,950 +2	+0%	+$372	0.49%	34
2025 Q1	$1.04M	Buy	4,948 +1,190	+32%	+$231K	0.58%	33
2024 Q4	$668K	Buy	3,758 +2	+0.1%	+$368	0.34%	44
2024 Q3	$742K	Buy	3,756 +2	+0.1%	+$373	0.39%	40
2024 Q2	$644K	Buy	3,754 +2	+0.1%	+$331	0.37%	41
2024 Q1	$683K	Buy	3,752 +2	+0.1%	+$345	0.41%	40
2023 Q4	$581K	Sell	3,750 -158	-4%	-$23K	0.39%	40
2023 Q3	$583K	Sell	3,908 -69	-2%	-$10.1K	0.44%	36
2023 Q2	$536K	Buy	3,977 +5	+0.1%	+$733	0.42%	42
2023 Q1	$633K	Buy	+3,972	New	+$607K	0.54%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Resolute Wealth Strategies's ABBV Position: Q2 2026 in Review

Resolute Wealth Strategies reduced its AbbVie (ABBV) stake by 7.3% in Q2 2026, selling an estimated $79K and leaving 4,658 shares worth $1.17M. The position accounts for 0.45% of the portfolio, ranked #37.

Resolute Wealth Strategies first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Resolute Wealth Strategies held 4,658 shares of AbbVie worth $1.17M as of Q2 2026.
Resolute Wealth Strategies sold 367 AbbVie shares in Q2 2026, an estimated $79K.
AbbVie made up 0.45% of Resolute Wealth Strategies's portfolio in Q2 2026, its #37 holding.
Resolute Wealth Strategies first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Resolute Wealth Strategies's 13F filing for Q2 2026, filed 12 Aug 2026.